Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets

MILAN--(BUSINESS WIRE)--Sep 28, 2026--

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world’s smallest, durable automated insulin delivery system for people living with diabetes, 1 is now available in 12 countries outside the United States. The company is now taking orders and shipping to eligible customers in Belgium, the Czech Republic, Denmark, Finland, Germany, Israel, Italy, Luxembourg, Spain, Sweden, Switzerland, and the United Kingdom.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260928831177/en/

Tandem Mobi is powered by Control-IQ+ technology, the predictive algorithm that automates insulin delivery. The system uses a Dexcom G7 continuous glucose monitoring system to predict glucose levels 30 minutes ahead and automatically adjust insulin delivery every 5 minutes to help reduce high and low blood sugar. Tandem Mobi also offers multiple wear options, mobile app control through a compatible, personal iPhone, * and a 200-unit cartridge.

Control-IQ+ technology has been evaluated in studies of people with type 1 diabetes, type 1 diabetes during pregnancy, and type 2 diabetes, including studies published by the New England Journal of Medicine and the Journal of the American Medical Association, with results showing immediate and sustained glycemic improvements, including more time in range and improved sleep. 2-6

“This expansion of Tandem Mobi access is an exciting next step in our strategy to offer a differentiated portfolio of durable insulin pumps to more people around the world,” said Igor Friedmann, senior vice president, international. “We look forward to increasing access to Tandem Mobi in more countries in the coming months.”

Attendees of the 62nd Annual Meeting of the European Association for the Study of Diabetes (EASD) can visit Tandem Diabetes Care at Booth B.02 to see a live demo of the Tandem Mobi system. The booth will be open for visitors on Tuesday, 29 September through Thursday, 1 October between 9:30-16:30.

Key Tandem Mobi System Features:

People living with diabetes interested in the Tandem Mobi system in the above countries can learn more at: www.tandemdiabetes.com/mobi.

About Tandem Diabetes Care

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ+ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.

* The mobile app requires a compatible smartphone model and operating system (sold separately). Visit tandemdiabetes.com/compatibility for a complete list of compatible smartphone models and operating systems.

† Do not wear or place your pump more than 12 inches (30.5 cm) above your infusion site. Doing so may result in over delivery of insulin.

‡ If glucose values are predicted to be above 10.0 mmol/L, Control-IQ+ technology calculates an AutoBolus using the Personal Profile settings and a target of 6.1 mmol/L and delivers 60% of that value.

References

1. As of Sept. 2026. Data on file, Tandem Diabetes Care.

2. Brown SA, Kovatchev BP, Raghinaru D, et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. N Engl J Med 2019;381:1707-1717 DOI: 10.1056/NEJMoa1907863

3. Breton MD, Kanapka LG, Beck RW, et al. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes, N Engl J Med 2020;383:836-845. DOI: 10.1056/NEJMoa2004736

4. Wadwa RP, Reed ZW, Buckingham BA, et al. Trial of Hybrid Closed-Loop Control in Young Children with Type 1 Diabetes. N Engl J Med. 2023;388:991-1001. DOI: 10.1056/NEJMoa2210834

5. Kudva YC, Raghinaru D, Lum JW, et al. A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes. N Engl J Med 2025;392:1801-1812. DOI: 10.1056/NEJMoa2415948

6. Donovan LE, Lemieux P, Dunlop AD, et al. Closed-Loop Insulin Delivery in Type 1 Diabetes in Pregnancy: The CIRCUIT Randomized Clinical Trial. JAMA. 2025;334(24):2176-2185. doi:10.1001/jama.2025.19578

Important Safety Information

For important safety information, please visit tandemdiabetes.com/safetyinfo.

Forward-looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to, among other things, our ability to increase access to Tandem Mobi in additional countries in the future. These statements are subject to numerous risks and uncertainties, including the risks associated with our ability to sustain commercial scale of Tandem Mobi pumps and the risk that we may encounter other challenges that may delay the availability of Tandem Mobi pumps, the compatibility with Android, or the integration with additional sensors in additional countries. These and other risks are identified and described in greater detail under the “Risk Factors” heading of our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other documents filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Actual results could differ materially from those anticipated or projected in the forward-looking statements. Tandem undertakes no obligation to update or review any forward-looking statement in this press release because of new information, future events, or other factors.

© 2026 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Tandem logos, Tandem Mobi, Control-IQ+, AutoBolus, and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. All other third-party marks are the property of their respective owners.

Tandem Mobi, the world’s smallest, durable insulin delivery system, now shipping in multiple international markets.

Tandem Mobi, the world’s smallest, durable insulin delivery system, now shipping in multiple international markets.

DETROIT (AP) — Three people were killed and four more were injured when an argument led to gunfire at an after-hours strip club Sunday morning in Detroit, officials said.

Police responding to the 7:21 a.m. shooting on a largely residential street found three men who had been fatally shot, Detroit Police Chief Todd Bettison told reporters at a news conference.

Four more people — two men and two women — were taken in private cars to area hospitals. None are thought to have life-threatening injuries.

All the victims are thought to be in their 20s and 30s, Bettison said.

“A fight occurred, an altercation occurred, and as a result individuals decided to settle it with gun violence,” he said.

“This address is not new to the Detroit Police Department,” he said, noting police had seven calls to the location this year. He said the department had leads but wouldn’t discuss them any further.

“This was an after-hours location,” he said of the shooting scene. “Imagine a strip club. … I'll leave it at that.”

Detroit Mayor Mary Sheffield urged anyone with information to contact authorities.

“We know that we need more people to speak up to bring justice to the situation,” she said at the news conference. “It’s heartbreaking and our community should not suffer from this type of violence.”

Earlier Sunday, a shooting broke out at a birthday party at a park in Macon, Georgia, leaving 12 teens with gunshot wounds, Bibb County Sheriff David Davis said during a news conference. Two of the injured were in critical condition, while the others were stable. There were no immediate arrests, but Davis said investigators had several persons of interest.

In this image taken from video provided by WXYZ, Detroit Police Chief Todd Bettison responds to questions during a news conference about a fatal shooting in Detroit on Sunday, Sept. 27, 2026. (WXYZ via AP)

In this image taken from video provided by WXYZ, law enforcement respond to a fatal shooting in Detroit on Sunday, Sept. 27, 2026. (WXYZ via AP)